NO20072192L - Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater - Google Patents

Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater

Info

Publication number
NO20072192L
NO20072192L NO20072192A NO20072192A NO20072192L NO 20072192 L NO20072192 L NO 20072192L NO 20072192 A NO20072192 A NO 20072192A NO 20072192 A NO20072192 A NO 20072192A NO 20072192 L NO20072192 L NO 20072192L
Authority
NO
Norway
Prior art keywords
preparation
intermediates
new product
azetidine derivatives
azetidin
Prior art date
Application number
NO20072192A
Other languages
English (en)
Inventor
Michel Lavigne
Luc Grondard
Stephane Mutti
Jorg Rieke-Zapp
Joel Malpart
Veronique Crocq-Stuerga
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20072192L publication Critical patent/NO20072192L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Det er beskrevet en ny fremgangsmåte for fremstilling av azetidinderivater, så som N{ l-[bis(4- klorfienyl)metyl]azetidin-3-yl}-N-kinol-6-yl-metylsulfionwnid og diklorhydratet derav og N-{l-[bis-(4- klorfienyl)metyl]azetidin-3-yl}-N-(3,5difluorfienyl)-metylsulfioiiamid.
NO20072192A 2004-10-14 2007-04-27 Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater NO20072192L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0410844A FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
PCT/FR2005/002490 WO2006040465A2 (fr) 2004-10-14 2005-10-10 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Publications (1)

Publication Number Publication Date
NO20072192L true NO20072192L (no) 2007-04-27

Family

ID=34954419

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072192A NO20072192L (no) 2004-10-14 2007-04-27 Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater

Country Status (21)

Country Link
US (1) US7687493B2 (no)
EP (1) EP1805167A2 (no)
JP (1) JP2008516932A (no)
KR (1) KR20070063544A (no)
CN (1) CN101039931A (no)
AR (1) AR051390A1 (no)
AU (1) AU2005293454A1 (no)
BR (1) BRPI0516507A (no)
CA (1) CA2583992A1 (no)
EA (1) EA011408B1 (no)
EC (1) ECSP077332A (no)
FR (1) FR2876688B1 (no)
IL (1) IL181904A0 (no)
MA (1) MA29513B1 (no)
MX (1) MX2007003923A (no)
NO (1) NO20072192L (no)
SG (1) SG155193A1 (no)
TN (1) TNSN07097A1 (no)
TW (1) TW200630358A (no)
WO (1) WO2006040465A2 (no)
ZA (1) ZA200702528B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045539B (zh) * 2021-03-30 2021-12-07 苏州大学 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709887D0 (en) * 1987-04-27 1987-06-03 Univ Alberta Alkyl azodicarboxylates
US5530134A (en) * 1994-09-06 1996-06-25 Synphar Laboratories Inc. Synthesis of anabaseine, salts and derivatives thereof
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
ATE450504T1 (de) * 2000-08-10 2009-12-15 Mitsubishi Tanabe Pharma Corp Prolinderivative und deren verwendung als medikamente
CN101407471A (zh) * 2003-08-29 2009-04-15 小野药品工业株式会社 能够结合s1p受体的化合物及其药物用途

Also Published As

Publication number Publication date
TNSN07097A1 (fr) 2008-06-02
EP1805167A2 (fr) 2007-07-11
EA200700840A1 (ru) 2007-08-31
AR051390A1 (es) 2007-01-10
CA2583992A1 (fr) 2006-04-20
ECSP077332A (es) 2007-04-26
ZA200702528B (en) 2008-07-30
JP2008516932A (ja) 2008-05-22
FR2876688A1 (fr) 2006-04-21
CN101039931A (zh) 2007-09-19
AU2005293454A1 (en) 2006-04-20
US7687493B2 (en) 2010-03-30
IL181904A0 (en) 2007-07-04
TW200630358A (en) 2006-09-01
BRPI0516507A (pt) 2008-09-16
MA29513B1 (fr) 2008-06-02
EA011408B1 (ru) 2009-02-27
SG155193A1 (en) 2009-09-30
US20070270463A1 (en) 2007-11-22
WO2006040465A3 (fr) 2006-08-10
WO2006040465A2 (fr) 2006-04-20
MX2007003923A (es) 2007-06-07
KR20070063544A (ko) 2007-06-19
FR2876688B1 (fr) 2007-03-16

Similar Documents

Publication Publication Date Title
NO20076498L (no) Derivater av 4-(2-amino-1-hydroksyetyl)fenol som agonister av den betta2-adrenerge reseptoren
NO20060847L (no) Substituert 2-aminotetralin til behandling av depresjon
RS53600B1 (en) UNITS, PREPARATIONS AND METHODS
NO20082145L (no) Prolinamidderivater som natriumkanalmodulatorer
NO20050828L (no) lndol-3-svovelderivater
ATE543807T1 (de) Verstärker von glutamat-rezeptoren
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
TW200624421A (en) Method for preparing n-phenylpyrazole-1-carboxamides
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
RS20050046A (en) 3-z-/1-(4-(n-((4-methyl-piperazin-1-yl)- methylcarbonyl)-n- methyl-amino)- anilino)-1-phenyl-methylene/-6- methoxycarbonyl -2-indolinone- monoethanesulphonate and the use thereof as a pharmaceutical composition
HN2005000016A (es) Procedimiento de preparacion
NO20054787L (no) Indenderivater som farmasotiske midler
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
TW200716582A (en) Process for making a pharmaceutical compound
RS51616B (en) HETEROARYL UREE DERIVATIVES USEFUL TO INHIBIT CHK1
TW200745039A (en) Isotopically substituted pantoprazole
NO20050019L (no) Polytylenglykolaldehyd-derivater
CY1112390T1 (el) Διαδικασια και ενδιαμεσα παρασκευης παραγωγων της ν-(1-βενζυδρυλ-αζετιδιν-3-υλ)-ν-φαινυλ-μεθυλσουλφοναμιδης
NO20072192L (no) Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater
WO2003106440A3 (en) PROCESS FOR THE SYNTHESIS OF A BENZAMIDE DERIVATIVE
DK1492767T3 (da) Visse 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer af serinproteasefaktoren XA
ATE442370T1 (de) Fungizide 6-phenyl-pyrazolopyrimidin-7-ylamine
HRP20030653B1 (en) Novel benzoylguanidine salt
AU2024202587A1 (en) Processes and intermediates for the preparation of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1h-pyrazole-4-carboxamide
SG145574A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application